Puretech Health plc (PRTC) Ordinary 1p
- Add to watchlist
- Create an alert
- This stock can be held in a
218.00p
218.00p
242.00p
£578.68 million
214.00p
213.50p
139.00p
n/a
2.00p (0.93%) Previous:
2.00p
324,641
n/a
2,000
Performance
1 week 1W | 0.71% | 1 year 1Y | 2.15% |
---|---|---|---|
1 month 1M | 3.82% | 2 years 2Y | 23.99% |
3 months 3M | 10.54% | 3 years 3Y | 48.43% |
6 months 6M | 43.24% | 5 years 5Y | 9.46% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Fundamental data
Year ending: | 31/12/2023 | 31/12/2022 |
---|---|---|
Revenue ($m) | 3.33 | 15.62 |
Profit before tax ($m) | (36.10) | (92.78) |
Adjusted EPS (¢): | (24.00) | (18.00) |
P/E ratio | n/a | n/a |
PEG | n/a | n/a |
EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: US dollar
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Puretech Health operating losses narrow in 'landmark year'
25 April 2024 10:07
-
PureTech founder steps down as CEO to lead SeaPort spin-off
9 April 2024 07:48
-
Puretech Health proposes $100m capital return
19 March 2024 09:46
-
Total Voting Rights
1 May 2024 07:00
-
Final Results
25 April 2024 07:00
-
Notice of Results
18 April 2024 07:00
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.